Nomic Bio

📍 Montreal, Canada🗓 Founded 2017👥 44 employees💰 Last funded Apr 2020
Biotechnology Research🌐 nomic.bio
Website LinkedIn
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Canada
1
Investor activity2019–2020 · investors recorded per year
2019120202
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Nomic Bio?
Nomic Bio has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Nomic Bio last raise funding?
The most recent investment in Nomic Bio recorded on gritt.io was in April 2020.
When was Nomic Bio founded?
Nomic Bio was founded in 2017.
What industry is Nomic Bio in?
Nomic Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Nomic Bio based?
Nomic Bio is headquartered in Montreal, Canada.